It's been a tough year for Novo Nordisk, the Danish pharmaceutical company behind the GLP-1 drugs Ozempic and Wegovy.

Some consumers take tiny doses of Ozempic and other GLP-1 drugs or stretch out doses to cut costs and side effects.

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients ...

The weight-loss industry is a huge one in the U.S. Numbers say it all, and the global weight management market size was ...